Jason Chung

Transomic Technologies, Inc. offers a comprehensive array of next-generation genomic modulation and gene editing tools that are used in cutting-edge life science research to advance our understanding of biological systems and facilitate the development of advanced therapeutics. At Transomic Technologies we believe deeply in the power of science and technology to improve the quality of life. Our company provides next-generation research tools to assist in helping unravel genetic complexities and contribute to our understanding of disease development. This mission, coupled with a deep understanding of the tools that life science researchers need, drives our focus to be a research partner; delivering technologies that are cost-effective and technically supported. These research tools for gene manipulation and cellular engineering provide investigators with high-quality CRISPR reagents, RNAi tools, full-length cDNAs and ORFs and lentiviral based delivery vectors for gene function analysis in relation to oncology, neuroscience, metabolic disorders, etc. For more information, visit Transomic Technologies’ website: http://www.transomic.com

Strategic Finance and Transaction Advisory Services

Transomic Technologies, Inc. offers a comprehensive array of next-generation genomic modulation and gene editing tools that are used in cutting-edge life science research to advance our understanding of biological systems and facilitate the development of advanced therapeutics. At Transomic Technologies we believe deeply in the power of science and technology to improve the quality of life. Our company provides next-generation research tools to assist in helping unravel genetic complexities and contribute to our understanding of disease development. This mission, coupled with a deep understanding of the tools that life science researchers need, drives our focus to be a research partner; delivering technologies that are cost-effective and technically supported. These research tools for gene manipulation and cellular engineering provide investigators with high-quality CRISPR reagents, RNAi tools, full-length cDNAs and ORFs and lentiviral based delivery vectors for gene function analysis in relation to oncology, neuroscience, metabolic disorders, etc. For more information, visit Transomic Technologies’ website: http://www.transomic.com

Caxton Associates, founded in 1983, is a global trading and investment firm with offices in New York, London, Monaco, Singapore and Dubai. Caxton Associates’ primary business is to manage client and proprietary capital through a suite of products designed to fit the specific needs of investors. Employing a multi-portfolio manager framework, Caxton excels in discretionary global macro investing, leveraging its diversified expertise across asset classes and markets.

The White Stone Group™ was acquired in September 2015, and now is proud to be a part of Vyne Medical™. We are thrilled to have the resources of Vyne™ to accelerate the growth and functionality of Trace™ and our other technology solutions to better serve our loyal healthcare clients and partners. Please join our new LinkedIn page at linkedin.com/company/vyne-medical.